Zydus Lifesciences Ltd Half Yearly Results

Gross Sales

11,413.7

11,160.1

9,710.1

9,311.4

9,012.3

Excise Duty

0

0

0

0

0

Net Sales

11,413.7

11,160.1

9,710.1

9,311.4

9,012.3

Other Operating Income

383.3

284.4

328.9

197

17.7

Other Income

137.8

131.7

217.1

90

76.3

Total Income

11,934.8

11,576.2

10,256.1

9,598.4

9,106.3

Total Expenditure

8,503.5

7,899.1

7,304.1

6,873.2

7,421.5

PBIDT

3,431.3

3,677.1

2,952

2,725.2

1,684.8

Interest

108.6

57.3

54.4

26.8

60.5

PBDT

3,322.7

3,619.8

2,897.6

2,698.4

1,624.3

Depreciation

466.9

448.9

400.1

364

360.2

Minority Interest Before NP

0

0

0

0

0

Tax

1,029.9

1,019.4

614.6

878

358.6

Deferred Tax

-427.2

-210.2

-79.6

-435.5

-26.2

Reported Profit After Tax

2,253.1

2,361.7

1,962.5

1,891.9

931.7

Minority Interest After NP

75.5

71.6

64.1

49.2

69.9

Net Profit after Minority Interest

2,194.4

2,331.1

1,971.9

1,887.6

919.5

Extra-ordinary Items

-219.9

0.3

25

-10.86

-603.1

Adjusted Profit After Extra-ordinary item

2,414.3

2,330.8

1,946.9

1,898.46

1,522.6

EPS (Unit Curr.)

21.81

23.17

19.6

18.65

9.09

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

100.6

100.6

100.6

101.2

101.2

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

30.06

32.94

30.4

29.26

18.69

PBDTM(%)

-

-

-

-

-

PATM(%)

19.74

21.16

20.21

20.31

10.33